Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최찬범 | - |
dc.date.accessioned | 2018-03-09T01:08:13Z | - |
dc.date.available | 2018-03-09T01:08:13Z | - |
dc.date.issued | 2013-10 | - |
dc.identifier.citation | International Journal of Rheumatic Diseases, 2015, 18(3), P.315-322 | en_US |
dc.identifier.issn | 1756-1841 | - |
dc.identifier.issn | 1756-185X | - |
dc.identifier.uri | http://onlinelibrary.wiley.com/doi/10.1111/1756-185X.12515/abstract | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/43892 | - |
dc.description.abstract | AimThe aim of this study was to evaluate the occurrence of active tuberculosis (TB) in patients who received both an interferon-gamma release assay (the QuantiFERON-TB Gold In-Tube test [QFT-GIT]) and tuberculin skin test (TST) in comparison with those who received QFT-GIT or TST alone for the detection of latent TB infection (LTBI).MethodsIn total, 842 patients who received QFT-GIT or TST and used biologic agents between January 2007 and December 2012 were recruited to determine the usefulness of LTBI screening tests. The incidence of active TB was calculated relative to the LTBI screening method as the number of events per 100 000 person-years exposure.ResultsTB occurred in two of the patients who complied with an LTBI prophylaxis strategy. The TB incidence in the group that received both QFT-GIT and TST was 151.05 (95% confidence interval [CI] 150.11?151.98)/100 000 person-years, and the incidence was 169.78 (95% CI 168.73?170.84)/100 000 person-years in the group that received only TST.ConclusionTB occurred even in some patients who received LTBI prophylaxis in compliance with national guidelines. The incidence of TB in patients who received either the QFT-GIT plus TST prophylaxis strategy or the TST prophylaxis strategy alone was higher than the annual incidence of the general population of the Republic of Korea. It is not possible to conclude which of the LTBI prophylaxis strategies is superior. | en_US |
dc.description.sponsorship | This work was supported by research funding fromBMS Pharmaceutical Korea Limited and by a grant fromthe Korea Healthcare Technology R&D Project, Ministryof Health and Welfare, Republic of Korea (no.HI10C2020). | en_US |
dc.language.iso | en | en_US |
dc.publisher | 2014 Asia Paci?c League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd | en_US |
dc.subject | biologic agent | en_US |
dc.subject | interferon-gamma release assay | en_US |
dc.subject | latent tuberculosis infection | en_US |
dc.subject | QuantiFERON-TBGold In-Tube test | en_US |
dc.subject | tuberculin skin test | en_US |
dc.title | Evaluation Of The Usefulness Of Interferon-Gamma Release Assays and Tuberculin Skin Test For Detection Of Latent Mycobacterium Tuberculosis Infection In Korean Rheumatic Patients With Biologic Agents. | en_US |
dc.type | Article | en_US |
dc.relation.no | Special SI | - |
dc.relation.volume | 65 | - |
dc.identifier.doi | 10.1111/1756-185X.12515 | - |
dc.relation.page | 560-560 | - |
dc.relation.journal | ARTHRITIS AND RHEUMATISM | - |
dc.contributor.googleauthor | Kim, Jae-Hoon | - |
dc.contributor.googleauthor | Won, Soyoung | - |
dc.contributor.googleauthor | Choi, Chan-Bum | - |
dc.contributor.googleauthor | Sung, Yoon-Kyoung | - |
dc.contributor.googleauthor | Song, Gwan Gyu | - |
dc.contributor.googleauthor | Bae, Sang-Cheol | - |
dc.relation.code | 2013009027 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | cbchoi | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.